Akebia Therapeutics | AKBA - Current Assets


Akebia Therapeutics reported $229.55M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.22B 128.53M Jun/2026
Agios Pharmaceuticals USD 717.67M 117.18M Jun/2026
Akebia Therapeutics USD 229.55M 13.93M Jun/2026
Alnylam Pharmaceuticals USD 4.62B 400.86M Jun/2026
Amgen USD 34.96B 3.49B Jun/2026
Ardelyx USD 381.87M 447K Mar/2026
Astellas Pharma JPY 1.49T 63.68B Jun/2026
AstraZeneca USD 27.97B 1.65B Jun/2026
Bayer EUR 33.64B 1.66B Jun/2026
BioMarin Pharmaceutical USD 3.97B 633.45M Jun/2026
Celltrion KRW 481.57B 10.97B Mar/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 897.54M 222.37M Jun/2026
Exelixis USD 1.25B 42.18M Jun/2026
Fresenius Medical Care EUR 7.69B 418.66M Jun/2026
GlaxoSmithKline GBP 17.56B 202M Jun/2026
Ionis Pharmaceuticals USD 2.49B 446.73M Jun/2026
Ironwood Pharmaceuticals USD 332.29M 58.11M Mar/2026
J&J USD 59.77B 601M Jun/2026
Kangmei Pharma CNY 6.8B 225.83M Mar/2026
Karyopharm Therapeutics USD 126.33M 23.19M Mar/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Lexicon Pharmaceuticals USD 186.03M 84.14M Mar/2026
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Moderna USD 5.82B 45M Jun/2026
Nektar Therapeutics USD 589.04M 322.77M Mar/2026
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Organigram Holdings CAD 250.09M 6.46M Mar/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Pharma Mar EUR 280.95M 7.5M Jun/2026
Prothena USD 292.01M 47.19M Jun/2026
PTC Therapeutics USD 2.62B 363.36M Jun/2026
Qiagen NV USD 1.66B 116.37M Jun/2026
Regeneron Pharmaceuticals USD 18.45B 236.8M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 31.52B 1.36B Jun/2026
Sarepta Therapeutics USD 2.22B 86.05M Jun/2026
Sartorius EUR 1.64B 280M Jun/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Tectonic Therapeutic USD 239.89M 17.47M Mar/2026
Tilray USD 729.32M 28.18M Sep/2025
Vanda Pharmaceuticals USD 347.26M 20.23M Dec/2025
Zealand Pharma A/S 15.02B 652.12M Mar/2026
Zz Pientze Pharmaceu CNY 11.16B 270.46M Jun/2026